Novo Nordisk initiates share buyback scheme and acquires shares from owner
The Danish pharmaceutical giant has started a share buyback program and bought DKK 3.4bn (USD 480m) in shares from its owner, Novo Holdings.
by marketwire, translated by catherine brett
As part of its DKK 24bn (USD 3.4bn) share buyback plan for 2022, Novo Nordisk started the process of acquiring DKK 4.4bn (USD 620m) of its own shares on Wednesday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Eli Lilly wants to gain on Novo Nordisk's obesity lead
For subscribers
Novo Nordisk remains coy over Wegovy blockbuster potential
For subscribers
Novo Nordisk confirms start of phase I robotic pill trial
For subscribers
